Supra? RGI was of the opinion that they could transfer the licence from BC to ON, HC formed a different opinion hence that falling by the wayside. In the end we wound up with a much cheaper, although just as drawn out, deal with CanniFarms.
Gibio? They want/need more cash, RGI don't have the cash and aren't prepared to outlay cash they don't have. Is that a bad thing? Gibio has not entirely fallen by the wayside so something might still happen in that respect although looking very doubtful.
Delays with others?
Thailand/Malaysia is moving along nicely, not as quick as shareholders would necessarily like but the current environment is not conducive to quick action.
CanniFarms is dragging but then without being a fly on the wall who can say exactly why this is dragging out as long as it is.
Malta? Poor choice of company to make a deal with, former management were much like RQB and have basically left the company a shell with no money.
Portugal and others? I am fairly confident that the alleged patent breach by RQB has had an impact on the delays.
RGI Price at posting:
6.5¢ Sentiment: Hold Disclosure: Held
